| Literature DB >> 34996448 |
Yiyuan Luo1, Juan Wang1, Shuo Li1, Yue Wu1, Zhirui Wang1, Shaojun Chen1, Hongjiang Chen2,3.
Abstract
BACKGROUND: Bletilla striata is the main medicine of many skin whitening classic formulas in traditional Chinese medicine (TCM) and is widely used in cosmetic industry recently. However, its active ingredients are still unclear and its fibrous roots are not used effectively. The aim of the present study is to discover and identify its potential anti-melanogenic active constituents by zebrafish model and molecular docking.Entities:
Keywords: Anti-melanogenic activity; Antioxidant; Bletilla striata; Molecular docking; UPLC-Q-TOF-MS/MS; Zebrafish
Mesh:
Substances:
Year: 2022 PMID: 34996448 PMCID: PMC8742349 DOI: 10.1186/s12906-021-03492-y
Source DB: PubMed Journal: BMC Complement Med Ther ISSN: 2662-7671
Fig. 1Base peak chromatogram of 95% ethanol extracts from B. striata tubers (A) and fibrous roots (B)
The compounds identified from the 95% ethanol extracts from B. striata tubers and fibrous roots by UPLC-Q-TOF-MS/MS, and their relative peak areas
| NO. | TR (min) | Formula | Found Mass | [M + H]− | Error (ppm) | Identification | Relative peak areas (× 106) | |
|---|---|---|---|---|---|---|---|---|
| ETB | EFB | |||||||
| 1 | 2.35 | C13H18O7 | 285.0977 | 161.0450, 123.0444, 105.0352 | −0.8 | gastrodin | 2.17 | 1.43 |
| 2 | 4.53 | C7H6O3 | 137.0248 | 137.0244, 108.0224, 92.0275 | 3.1 | – | 0.77 | |
| 3 | 6.70 | C9H8O3 | 163.0406 | 145.8896, 119.0505, 93.0361 | 3.2 | 3-hydroxycinnamic acid | – | 0.43 |
| 4 | 7.01 | C34H32O8 | 567.2028 | 457.1678, 393.1388, 285.0978, 161.0454, 153.0573, 129.0579 | 0.6 | bleochranol D | – | 2.80 |
| 5 | 7.71 | C40H56O22 | 887.3179 | 707.2520, 619.2221, 439.1590 | −1.3 | dactylorhin A | 3.93 | 3.06 |
| 6 | 8.13 | C21H22O8 | 401.1228 | 284.0313, 255.0290, 238.0630, 227.0337, 195.0465 | −3.6 | 2,7-dihydroxy-4-methoxyphenanthrene-2-O-glucoside | – | – |
| 7 | 8.21 | C27H32O13 | 563.1747 | 540.6504, 429.8704, 394.1452, 320.7833, 310.8648 | −4.1 | 2,7-dihydroxy-4-methoxyphenanthrene-2,7-O-diglucoside | – | 1.18 |
| 8 | 9.62 | C34H46O17 | 725.2635 | 457.1673, 285.0954, 171.0654, 153.0551, 123.0451 | −3.8 | militarine | 30.48 | 38.39 |
| 9 | 9.76 | C20H22O6 | 357.1332 | 313.0688, 225.0513, 181.0614, 121.0287, 77.0403 | −3.3 | pinoresinol | – | – |
| 10 | 10.31 | C21H26O8 | 405.1537 | 243.1015, 227.0705, 201.0893, 136.0531, 122.0400 | −4.5 | 3′-hydroxy-5-methoxybibenzyl-3-O- | 0.72 | 1.56 |
| 11 | 11.08 | C16H12O5 | 283.0601 | 237.0654, 211.0864, 75.0467 | −3.8 | 1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione | – | 1.53 |
| 12 | 12.15 | C15H13O4 | 256.0734 | 239.0345, 211.0401, 201.8356, 167.0496, 143.0501 | −3.0 | 7-hydroxy-2-methoxyphenanthrene-3,4-dione | – | – |
| 13 | 12.42 | C15H12O3 | 239.0714 | 224.0466, 196.0523, 167.0491 | 0.3 | 4-methoxyphenanthrene-2,7-diol | – | 1.92 |
| 14 | 12.99 | C16H14O4 | 269.0820 | 254.0563, 211.0388, 183.0448 | 0.2 | 2,7-dihydroxy-3,4-dimethoxyphenanthrene | – | 6.01 |
| 15 | 13.54 | C51H64O24 | 1059.3674 | 791.2752, 661.2301, 569.1989, 439.1569, 153.0557 | −3.8 | gymnoside X | 1.07 | 0.89 |
| 16 | 13.64 | C28H26O5 | 441.1691 | 347.1255, 253.0852, 241.0868, 211.0751, 93.0360 | −3.7 | shanciguol | – | 1.51 |
| 17 | 13.80 | C16H18O4 | 273.1126 | 243.1036, 227.0700, 185.0636, 136.0516, 122.0372, 106.0415 | −2.2 | 3,3′-dihydroxy-5,4′-dimethoxybibenzyl | – | – |
| 18 | 13.88 | C15H16O3 | 243.1026 | 227.0707, 183.0810, 136.0537, 93.0357 | −0.4 | 3,3′-dihydroxy-5-methoxybibenzyl | – | 1.80 |
| 19 | 14.07 | C22H20O4 | 347.1278 | 332.1024, 237.0561, 225.0549, 209.0622, 93.0352 | −3.2 | 4,7-dihydroxy-1-( | 0.32 | – |
| 20 | 14.26 | C29H24O5 | 451.1507 | 437.1341, 392.1347, 329.0777, 224.0484 | −9.8 | 1,8- | – | 8.73 |
| 21 | 14.31 | C22H18O4 | 345.1124 | 330.0875, 302.0909, 237.0545 | −2.4 | 1-( | 0.25 | – |
| 22 | 14.50 | C25H24O6 | 419.1480 | 405.1118, 377.1172, 225.0548 | −4.8 | bleochranol B | 0.21 | 1.89 |
| 23 | 14.67 | C23H20O5 | 375.1225 | 360.0979, 317.0802, 224.0484 | −3.6 | bleformin B | – | 5.08 |
| 24 | 14.71 | C30H26O6 | 481.1631 | 465.1301, 434.1102, 419.1264, 225.0548 | −5.3 | blestrin A | 0.79 | 5.08 |
| 25 | 14.89 | C22H22O4 | 349.1434 | 243.1017, 227.0704, 183.0810, 93.0356 | −3.1 | 3,3′-dihydroxy-4-( | – | – |
| 26 | 14.94 | C30H24O6 | 479.1478 | 464.1236, 432.0980, 421.1041, 379.0948, 238.0631, 224.0478, 196.0533 | −4.6 | blestrin D | 0.46 | 1.91 |
| 27 | 15.53 | C32H26O8 | 537.1529 | 522.1312, 507.1027, 492.0773, 464.0849, 421.0668, 377.0799, 209.8293, 130.9680 | −4.9 | 4,8,4′,8′-tetramethoxy-[1,1′-biphenanthrene]-2,7,2′,7′-tetrol | 0.01 | 9.15 |
| 28 | 15.74 | C37H32O7 | 587.2047 | 571.1716, 543.1831, 527.1544, 476.1243, 449.1367, 434.1257, 270.2400, 224.0534, 152.9984 | −4.9 | bleformin D | – | 9.63 |
| 29 | 16.08 | C15H14O3 | 241.0869 | 226.0615, 183.0449, 169.0667 | −0.7 | 2,4-dimethoxyphenanthrene-7-ol | 0.13 | 1.48 |
| 30 | 16.49 | C27H26O7 | 461.1584 | 425.1723, 381.1463, 242.0897, 93.0338 | −4.7 | pleionesin C | 0.04 | 0.36 |
| 31 | 16.61 | C16H14O3 | 253.0862 | 238.0621, 223.0388, 195.0441, 167.0502 | −3.1 | 2-hydroxy-4,7-dimethoxyphenanthrene | 0.01 | 1.42 |
| 32 | 16.89 | C18H18O4 | 297.1126 | 253.0491, 239.0346, 225.0942, 211.0392, 166.0456 | −2.1 | 2,3,4,7-tetramethoxyphenanthrene | 0.01 | 2.28 |
| 33 | 16.94 | C29H26O5 | 453.1671 | 438.1428, 345.1106, 251.0712, 195.0470, 93.0362 | −8.2 | 2,7-dihydroxy-1,6-bis( | 0.10 | 0.64 |
| 34 | 17.46 | C23H24O4 | 363.1585 | 333.1163, 255.0940, 227.0706, 199.0746, 157.0631, 93.0378 | −4.7 | bulbocol | 0.15 | 3.85 |
| 35 | 17.67 | C22H22O3 | 333.1486 | 163.1126, 107.0521, 75.0477 | −3.2 | 5-hydroxy-2-( | 0.60 | 3.34 |
| 36 | 18.27 | C27H35O9 | 502.2211 | 369.2416, 337.2141, 193.1229, 163.1124, 147.0816, 133.1056 | 0.5 | (20 | 9.14 | 1.06 |
| 37 | 18.30 | C18H30O3 | 293.2117 | 275.1976, 249.1821, 235.1714, 221.1501, 171.1030, 121.1041, 59.0153 | −1.7 | striatolide | – | 2.49 |
| 38 | 18.78 | C16H32O2 | 255.2327 | 238.027, 224.0464, 210.0314, 195.0444, 182.0355, 167.0502 | −1.0 | palmitic acid | – | 0.95 |
| 39 | 18.87 | C31H23O8 | 522.1329 | 508.1470, 493.1272, 450.1078, 253.0495, 225.0527, 210.0426 | 1.7 | 3′,7′,7-trihydroxy-2,2′,4′-trimethoxy-[1,8′-biphenanthrene]-3,4-dione | 7.20 | 0.76 |
- means the relative peak areas is less than 0.01 × 106
The results of antioxidant activity analyses in vitro (DPPH, ABTS and FRAP)
| Sample | IC50 values (mg/L) | FRAP | |
|---|---|---|---|
| DPPH scavenging | ABTS scavenging | ||
| PTB | 548.24 ± 8.93a | 626.49 ± 9.75a | 0.11 ± 0.01a |
| PFB | 285.81 ± 5.31b | 348.62 ± 6.30b | 0.42 ± 0.03b |
| ETB | 65.25 ± 1.85c | 78.40 ± 2.51c | 2.45 ± 0.05c |
| EFB | 5.94 ± 0.46d | 11.69 ± 0.64d | 6.92 ± 0.10d |
| Trolox | 3.52 ± 0.27e | 3.68 ± 0.31e | – |
Within a row, different letters (a, b, c, d and e) indicate significant differences with p < 0.05
Fig. 2The DPPH (A) and ABTS (B) radical scavenging activities of PTB, PFB, ETB, EFB, and Trolox
Fig. 3Impact of melanogenic inhibitors on relative tyrosinase activity (A) in vitro and melanin synthesis (B) in zebrafish embryos
Fig. 4The impacts of PTB, PFB, ETB and EFB on the melanin synthesis of zebrafish embryos (× 2 × 10 × 5.6)
Summary of binding affinities and ligand-amino acid interactions
| Protease | Ligand | Binding Energy (kcal/mol) | H-Bond | lipophilic |
|---|---|---|---|---|
| Tyrosinase | 1,8-bis(p-hydroxybenzyl)-4-methoxyphenanthrene-2,7-diol | −10.2 | – | Lys233, Leu229, Arg114, Glu451, Arg230, Pro115, Gly107, Pro445, Met452, Tyr226, Ser106, Asn459 |
| blestrin D | −10.0 | Arg114, Glu451 | Pro446, Pro445, Ser106, Gly107, Cys113, Lys233, Arg230, Pro115, Tyr226, Leu229, Met452 | |
| 2,7-dihydroxy-1,6-bis(p-hydroxybenzyl)-4-methoxy-9,10dihydrophenanthrene | −9.7 | Glu232, Gln236, Lys223, Cys113, Glu451, Ser106, | Leu229, Ile128, Pro115, Tyr226, Val447, Gly107, Thr112 | |
| Adenylate cyclase | blestrin D | −12.1 | Val167 | Leu166, Lys95, Phe45, Ala97, Asn412, Arg416, Ala415, Val172, Phe336, Phe338, Arg176, Leu102, Met337 |
| blestrin B | −11.9 | Met337, Val167 | Met419, Phe338, Phe45, Lys95, Leu166, Phe165, Phe336, Leu102, Ala97, Phe296, Ala415, Arg416 | |
| 3,3′,5-trimethoxybibenzyl | −11.6 | Asp47, Asn180 | Ala100, Leu345, Ala97, Phe336, Phe296, Met419, Ala415, Met418, Lys95, Leu166, Val335, Phe165, Leu102, Phe45, Phe338, Arg176, Gln179 |
Fig. 5Best calculated poses for blestrin D inside binding pocket of homology model of tyrosinase (A) and adenylate cyclase (B)
Qikprop calculated ADMET properties of the top three hits
| Compounds | MW | QPlog | QPlogS | QPP | QP | QPlog | QPlog | Human oral absorption (%) | Rule of five |
|---|---|---|---|---|---|---|---|---|---|
| 3,3′,5-trimethoxybibenzyl | 272.34 | 4.31 | − 6.02 | 9906.04 | − 0.15 | − 0.15 | −7.77 | 100.00 | 2 |
| 1,8-bis(p-hydroxybenzyl)-4-methoxyphenanthrene-2,7-diol | 452.51 | 4.70 | −6.25 | 149.72 | −1.98 | −2.81 | −6.66 | 93.41 | 0 |
| blestrin B | 482.53 | 5.55 | −7.26 | 661.17 | −1.17 | −2.10 | −6.29 | 96.94 | 1 |
| blestrin D | 482.53 | 5.50 | −7.47 | 452.82 | −1.39 | −2.43 | −6.40 | 93.71 | 1 |
| 2,7-dihydroxy-1,6-bis(p-hydroxybenzyl)-4-methoxy-9,10dihydrophenanthrene | 348.40 | 3.70 | −4.91 | 375.43 | −1.23 | −2.73 | −5.50 | 94.67 | 0 |
Recommended values: MW, 130.0–725.0; QPlogPo/w, −2 - 6.5; QPlogS, −6.5 - 0.5; QPPCaco < 25 is poor and > 500 is great; QPlogBB, −3 - 1.2; QPlogKp,–8.0 - –1.0; QPlog HERG, <− 5; human oral absorption (%) > 80% is high and < 25% is poor; rule of five, max 4
Fig. 6Dynamics of blestrin D bound to tyrosinase and adenylate cyclase. (A) The backbone RMSD of the protein along the simulation time. (B) RMSF for protein-inhibitor during MD simulation
Fig. 7Molecular interactions of blestrin D with tyrosinase (A) and adenylate cyclase (B). Dashed lines represent the H-bonds
Binding free energy (kcal/mol) of inhibitor-protein complexes along with the individual energy components (kcal/mol) contributions
| Contribution | Blestrin D-tyrosinase | Blestrin D-adenylate cyclase |
|---|---|---|
| △GVDW | −54.03 | −72.34 |
| △Gele | −11.48 | −28.68 |
| △GGB | 30.44 | 37.98 |
| △GGA | −61.71 | −78.47 |
| △Gbind | −96.94 | −139.69 |
△GVDW: The free energy of binding from the van der Waals energy, △Gele: The free energy of binding from the electrostatic energy, △GGB: The free energy of binding from the polar solvation energies, △GGA: The free energy of binding from the non-polar solvation, △Gbind: Free energy of binding